Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.52
-0.24 (-4.17%)
Mar 3, 2026, 4:00 PM EST - Market closed
Foghorn Therapeutics Employees
Foghorn Therapeutics had 112 employees as of December 31, 2024. The number of employees decreased by 4 or -3.45% compared to the previous year.
Employees
112
Change (1Y)
-4
Growth (1Y)
-3.45%
Revenue / Employee
$218,911
Profits / Employee
-$643,946
Market Cap
323.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 112 | -4 | -3.45% |
| Dec 31, 2023 | 116 | -45 | -27.95% |
| Dec 31, 2022 | 161 | 42 | 35.29% |
| Dec 31, 2021 | 119 | 24 | 25.26% |
| Dec 31, 2020 | 95 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sutro Biopharma | 178 |
| Puma Biotechnology | 172 |
| Neurogene | 107 |
| Rezolute | 75 |
| Immuneering | 54 |
| Protara Therapeutics | 33 |
| Avalo Therapeutics | 23 |
| Climb Bio | 18 |
FHTX News
- 7 days ago - Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 8 days ago - Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer - GlobeNewsWire
- 4 weeks ago - Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit - GlobeNewsWire
- 7 weeks ago - Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium - GlobeNewsWire
- 7 weeks ago - Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026 - GlobeNewsWire
- 3 months ago - Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 4 months ago - Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update - GlobeNewsWire
- 4 months ago - Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences - GlobeNewsWire